Skip to main content
. 2022 Feb 28;17(2):e0264775. doi: 10.1371/journal.pone.0264775

Fig 7. Measurements related to in vivo wound healing efficacy with variety of dosing regimen.

Fig 7

Wound closure (top row), contraction (middle row) and re-epithelialisation (bottom row) in db/db mice after administrating doses between 5x106 and 5x109 CFU/ml of AUP1602-C either on daily basis until day 6 (left column), every other day until day 12 (middle column) or every fourth day until day 20 (right column). Grey background indicates treatment period. Data is presented as group mean.